UK Markets closed

Idorsia Ltd (0RQE.L)

LSE - LSE Delayed price. Currency in CHF
Add to watchlist
21.16-5.11 (-19.46%)
At close: 5:02PM GMT
Full screen
Previous close26.27
Bid0.00 x 0
Ask0.00 x 0
Day's range26.18 - 26.84
52-week range26.18 - 26.84
Avg. volumeN/A
Market cap2.778B
Beta (5Y monthly)0.73
PE ratio (TTM)N/A
EPS (TTM)-2.83
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Globe Newswire

    Invitation to Idorsia's half year financial results 2021 webcast and conference call

    Idorsia will publish its half year financial results 2021 on Tuesday July 27, 2021, at 07:00 CEST. An investor conference call and webcast will be held to discuss the results on the same day. Date: Tuesday, July 27, 2021 Time: 14:00 CEST / 13:00 BST / 08:00 EDT The call will start with presentations by senior management, followed by a Q&A session. To support your preparations, the consensus estimates can be found under: Dial-in: Participants should start calli

  • Globe Newswire

    Idorsia initiates the Phase 3 registration study with selatogrel for the treatment of acute myocardial infarction

    Ad hoc announcement pursuant to Art. 53 LR Idorsia to host an investor webcast to discuss the Phase 3 study today at 14:30hrs CEST Allschwil, Switzerland – June 28, 2021Idorsia Ltd (SIX: IDIA) today announced the initiation of the Phase 3 registration study “SOS-AMI” to evaluate the efficacy and safety of self-administered subcutaneous selatogrel, Idorsia’s P2Y12 receptor antagonist, in suspected acute myocardial infarction (AMI). An AMI, or heart attack, is a life-threatening condition that occ

  • Globe Newswire

    Idorsia to present new Phase 3 data on daridorexant in insomnia at SLEEP 2021

    Allschwil, Switzerland – June 9, 2021 Idorsia Ltd (SIX: IDIA) today announced that nine abstracts for daridorexant, the company’s investigational dual orexin receptor antagonist for the treatment of adults with insomnia, will be presented at SLEEP 2021. The annual joint meeting of the American Academy of Sleep Medicine and the Sleep Research Society is conducted virtually from June 10-13. Antonio Olivieri, Senior Vice President, Head of Global Medical Affairs of Idorsia commented: “As a company